Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02866344 · ClinicalTrials.gov registry record · NA
Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02866344 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 1 participants.
The verdict
NCT02866344, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This single-center, prospective, randomized clinical trial is designed to compare the clinical characteristics and outcomes of hepatic resection and microwave ablation (MWA) to determine the optimal operative intervention for the local treatment of resectable colorectal cancer liver metastases. The primary aim of this study is to test the following hypothesis: 2-year local disease control is equivalent between patients receiving the experimental therapy (MWA) and patients receiving the standard therapy (hepatic resection) as treatment for colorectal cancer liver metastases determined to be resectable by radiographic imaging. Secondarily, the investigators expect that 2-year intrahepatic (regional) and metastatic disease recurrence rates are equivalent between the two treatment arms in this study.
Interventions
- PROCEDURE Microwave ablation
- PROCEDURE Hepatic resection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02866344
The ClinicalTrials.gov registry entry for NCT02866344 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Microwave ablation is the first listed.
NCT02866344 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02866344 about?
NCT02866344 is a clinical study titled "Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases". This single-center, prospective, randomized clinical trial is designed to compare the clinical characteristics and outcomes of hepatic resection and microwave ablation (MWA) to determine the optimal operative intervention for the local treatment of resectable colorectal cancer liver metastases. The ...
What is the current status of trial NCT02866344?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2016-08. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02866344?
The interventions under investigation include: Microwave ablation (PROCEDURE), Hepatic resection (PROCEDURE).
Who is sponsoring clinical trial NCT02866344?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.